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Background: Data on nosocomial infections in hospitals in low-income countries are scarce and often inconsistent.
The objectives of this study were to estimate the prevalence of nosocomial infections and antimicrobial drug use in
Benin hospitals.
Methods: All hospitals were invited to participate in the first national point prevalence study conducted between
10–26 October 2012 using the protocol developed by the “Hospitals in Europe Link for Infection Control through
Surveillance” (HELICS) project. Infection prevalence rates and the proportion of infected patients and exposure to
antimicrobials were assessed.
Results: Overall, 87% (39/45) of hospitals participated. Of 3130 inpatients surveyed, 972 nosocomial infections were
identified among 597 patients, representing an overall prevalence of infected patients of 19.1%. The most frequent
infections were related to the urinary tract (48.2%), vascular catheter use (34.7%), and surgical site (24.7%). 64.6% of
patients surveyed were treated with antibiotics, including a significant proportion (30%) of non-infected patients
and a high proportion of self-medication (40.8%). Resistance of leading nosocomial pathogens to antimicrobials
included methicillin-resistance (52.5%) among Staphylococcus aureus, vancomycin resistance among enterococci
(67.5%), cefotaxime resistance among Escherichia coli (67.6%), and ceftazidime resistance among Acinetobacter
baumannii (100%) and Pseudomonas aeruginosa (68.2%).
Conclusions: Benin has high nosocomial infection rates and calls for the implementation of new national infection
control policies. Patient safety education and training of all individuals involved in healthcare delivery will be critical
to highlight awareness of the burden of disease. The high use of antimicrobials needs to be addressed, particularly
their indiscriminate use in non-infected patients.
Keywords: Nosocomial infection, Prevalence, Antimicrobial resistance, Co-morbidity, Antibiotic use, Infection
control, National surveillance, Surveillance, Africa, Low-/middle-income countriesIntroduction
Nosocomial infections, also named healthcare-associated
infections (HAI), are a global problem in every hospital
around the world. Quantification of HAI is needed to help
justify resources dedicated to infection control. Recogni-
tion of the problem and its characteristics vary consider-
ably from country to country [1-3], but the “Hospitals in* Correspondence: taahoyo@yahoo.fr
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(HELICS) project has resolved this issue by creating a con-
sensus prevalence protocol [4].
Hospital infection control practices remain rudimen-
tary in the developing world, mostly due to severely limited
resources [5,6]. Furthermore, the concept of interrupting
HAI transmission takes on another meaning when patients’
relatives have to take up temporary residence in the hos-
pital to provide food, care, and comfort [5,7]. Reports of
HAI rates in African countries are scarce, particularly at na-
tional level [6,7]. However, several reports in the literatureLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Prevalence of patients infected by hospital type








ALL 3130 597 19.1
By region
North region 1175 353 30.0
South region 917 165 18.0
Central region 1038 79 7.6
By hospital type
Departmental 642 134 20.9
General hospital 1801 323 17.9
University hospital 665 132 20.5
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prevalence surveys have revealed rates ranging between
2.5% and 14.8% [8,9]. Data on causative pathogens are avail-
able from a few studies only and highlight the importance
of Gram-negative rods, particularly in surgical site infec-
tions [10,11], and coagulase-negative staphylococci (CNS)
responsible for bloodstream infection [11].
HAI surveillance helps to assess the magnitude of disease
in populations and constitutes the first step to prevention
[12,13]. We describe the results of the first national preva-
lence survey of HAI and antimicrobial resistance in Benin
and provide a global picture of the epidemiological situ-
ation in this country.
Material and methods
Study design
A national research group designed a one-day point preva-
lence survey in collaboration with international experts.
The invitation to participate was sent in July 2012 to all
hospital directors in Benin. Participation was voluntary,
but strongly encouraged. To ensure consistency across all
hospitals, it was decided to define HAI by the presence of
clinical symptoms and signs not laboratory results only.
The United States Centers of Disease Control and Preven-
tion (CDC) criteria [13] were used to identify HAIs, based
on the presence of symptoms. Asymptomatic bacteriuria
was not recorded as a HAI.
The survey was conducted from 10 to 26 October 2012;
patients from the same ward were surveyed the same day
in each hospital. Data were collected by nurses and epide-
miologists trained for this purpose [13,14] by applying the
HELICS project prevalence protocol [4]. The feasibility of
the approach was assessed in a pilot study conducted in
March 2012. Patient characteristics and types of HAI were
recorded on case report forms. Only HAIs occurring in
the acute hospital setting were considered, thus excluding
for example, long-stay psychiatric wards and day care ac-
tivities, such as the outpatient day clinic. Infections devel-
oping after discharge were not included.
The study protocol was approved by each local ethics
committee. Due to the observational character of the study,
written informed consent was not required.
Microbiology
Bacterial samples were collected as recommended by
Freney et al. [15]. S. aureus strains were primarily inves-
tigated for morphological and biochemical characteris-
tics, including Gram stain, aerobic, anaerobic optional,
catalase, acetone, and coagulase-producing. Standard
microbiological methods for identification of microor-
ganisms were applied for others.
Antimicrobial susceptibility testing was performed by
agar diffusion method on Mueller Hinton agar (Bio-
Rad-Diagnostic Pasteur, Marnes la Coquette, France) asrecommended by the United States Clinical and Labora-
tory Standards Institute (CLSI) [16]. Interpretation of anti-
microbial susceptibility followed the recommendations of
the Antibiogram Committee of the French Society for
Microbiology Society. Evaluation of methicillin resist-
ance was performed by plating the strains on buffered
Mueller-Hinton (Bio-Rad-Diagnostic Pasteur) with NaCl
2% (wt/vol) at 37°C for 24 h.
Statistical analysis
A distinction was made between the prevalence of patients
infected (several infections by the same patient were
counted only once) and the prevalence of HAI (several in-
fections by the same patient were counted separately). All
statistically significant variables were analyzed using a
logistic regression model to demonstrate associations be-
tween individual variables and organism acquisition. Two-
tailed p values of < 0.05 were considered statistically
significant. All statistical analyses were performed using
SPSS software (SPSS 19.0 for Windows).
Results
Overall results
Data were collected from 39 of 45 healthcare facilities
(87%) and represented a total of 3761 beds, corresponding
to 65% of the full capacity of participating centres. Of the
3130 inpatients surveyed, there were 972 infections among
597 patients. The average prevalence of infected patients
was 19.1% (95% confidence interval [CI], 15.8-22.4) and
the overall prevalence of infection was 31.0% (95% CI,
21.8–35.2). Table 1 shows the average prevalence of in-
fected patients according to the type of hospital and geo-
graphical region.
Surgical (182 cases; 30.5% of all HAI), internal medi-
cine (135 cases; 22.6%), and obstetrics and gynaecology
wards (115 cases; 19.3%) were the three services most af-
fected by HAI. On the days surveyed, 11% of patients
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to 14 days, and 36% for more than 15 days. Information
was not available for 8%. Overall mortality among infected
patients was 22% (131/597) within seven days following in-
fection onset versus 7.4% (189/2533) among non-infected
patients (odds ratio [OR], 2.9; 95% CI, 2.1-3.2).
Infection sites and microbiological results
The most frequent infections were urinary tract infection
(37.5%), intravascular catheter-associated (27%), and surgi-
cal site infection (19.2%), followed by lower respiratory
tract infection or pneumonia (11.7%), bloodstream infec-
tion (1.5%), and infections of other origins (3.1%). A total
of 972 microorganisms were identified during the study
period; 65% (n = 632) were Gram-negative, 30% (n = 291)
were Gram-positive, and 5% (n = 49) others. Most isolates
were obtained from pus (44.3%), urine (43.5%), and blood
cultures (10.1%). Table 2 shows the most frequently en-
countered microorganisms.Patient characteristics
Characteristics of infected patients (n = 597) show a bi-
modal age distribution with peaks at the extremes of age.
In the 15 to 44-year-old age group (53.8%), mean age was
26 years and infected patients were mostly female. By con-
trast, no such difference was observed among patients
older than 55 years (mean age, 62 years). Within these 597
patients, 59.3% were female, 40.7% were male, 34% have
married status, 32% single, 10% divorced, 7% widowed,
and 17% of unknown marital status. The occupation of in-
fected patients showed that most were engaged in agricul-
tural activities (40.4%), followed by civil servants (13.6%),Table 2 Distribution of the most frequently identified
nosocomial pathogens; 1st National Prevalence study,
Benin, October 2012
Microorganism (no. of isolates) (%)
Staphylococcus aureus (271) 27.9
Escherichia coli (221) 22.7
Pseudomonas aeruginosa (110) 11.3
Enterococci (102) 10.5
Other GNR (99) 10.2
CNS (47) 4.9
Salmonella spp. (41) 4.2
Undetermined (30) 3.1
Citrobacter spp (26) 2.7
Candida spp (15) 1.5
Acinetobacter baumanii (10) 1
Total (972) 100
GNR, Gram-negative rod-shaped bacteria not further identified;
CNS, coagulase-negative staphylococci.household services (12%), and traders (4.5%); 29.5% were
without any occupation.
At the time of HAI identification, 55% of 597 patients
had been admitted from home, 29% from another service
in the same hospital, and 16% from another hospital.
Multivariate logistic regression analysis showed that the
risk of developing a HAI was mainly related to catheter
use (OR, 1.7; 95% CI, 1.2-2.9), duration of stay (OR, 8.2;
95% CI, 5.4-9.3), and inappropriate (unneeded and non-
prescribe) use of antibiotics (OR, 5.7; 95% CI, 3.8- 7.4).
Antimicrobial susceptibility
Tables 3 and 4 show the antimicrobial susceptibility pat-
terns of the most frequently isolated bacterial pathogens.
The frequency of resistance to methicillin among S. aureus
isolates was high (52.5%); the frequency of resistance to
vancomycin among S. aureus isolates was 7.7%, and the
frequency of resistance to vancomycin among enterococci
was 67.5%.
The highest proportions of resistance among Gram-
negative isolates were observed against ampicillin (86.4%),
tetracycline (77.3%), amoxicillin/clavulanic acid (72.8%),
and trimethoprim/sulfamethoxazole (64%). There were no
clear-cut differences in antimicrobial susceptibilities among
the various serotypes of Salmonella isolates. Most Pseudo-
monas aeruginosa isolates produced an extended spectrum
beta-lactamase and were resistant to all potentially active
beta-lactams, with the exception of imipenem (second-line
drug not currently available in Benin); only 24 isolates
(22%) were susceptible to gentamicin and ciprofloxacin.
The main resistance patterns observed among identified
pathogens are summarized in Table 5.
Anti-infective treatment
The prevalence of anti-infective therapy was 64.6%
(2023/3130); 86.2% (514) of infected patients and 30% (760)Table 3 Resistance patterns of leading Gram-positive
bacterial isolates to main antimicrobial agents; 1st







Penicillin 98% 95% 68%
Oxacillin 52.5% 35% _
Ampicillin _ _ 62.7%
Amoxicillin clavulanate 55% 23% 23%
Tetracycline 85% 78% 74%
Erythromycin 37% 54% 26%
Chloramphenicol 36% 32% 18%
Gentamicin 45% 35% 62.3%
Trimethoprim sulfamethoxazole 64% 70% 51%
Vancomycin 4% 1% 67.5%
*Number of isolates tested.
Table 4 Resistance patterns of leading Gram-negative bacterial isolates to main antimicrobial agents; 1st National













Ampicillin 74 78 100 89 100 76%
Amoxicillin clavulanate 72.8% 70% 90% 76% 100% 56%
Ceftazidime 60% 55% 67.5% 64% 100% 63%
Tetracycline 78% 75% 77.3% 88% 80% 95%
Gentamicin 45% 35% 22% 26% 75% 9.5%
Trimethoprim sulfamethoxazole 65% 68% 64% 56% 62% 87%
Ciprofloxacin 18% 13% 22% 15% 16% 9%
Imipenem 0 0 0 0 0 0
*Number of isolates tested.
Table 6 Most frequently used antimicrobials; 1st National
Prevalence Study, Benin, October 2012
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remaining (13.8%) of infected patients did not receive
any antibiotic treatment. More than 35% of treated pa-
tients were receiving more than one antimicrobial. A
total of 4130 drugs were prescribed during the study
period. Of these, 6% were prescribed under their inter-
national nonproprietary name. One-third of prescrip-
tions (37.4%; 1547/4130) of an antibiotic resulted from
a doctor’s prescription. In 40.8% (1686/4130) of cases,
the drug was used as self-medication (without doctor’s
prescription). Details of antimicrobials used are shown
in Table 6.
Discussion
The first national point prevalence study was organized in
the context of the 1st International Conference of Health
Ministers of Africa (CIMSEF 2012) held in Cotonou, Benin,
from 10–12 December 2012 as data from Benin were not
available. The one-day prevalence survey methodology was
selected as the most effective way to generate necessary
data in a short time and with the potential to provide valu-
able information to guide future infection control interven-
tions using limited resources. Participation was high and
the global estimated coverage was approximately 87% of allTable 5 Major resistance patterns identified among
bacterial isolates; 1st National Prevalence study,
Benin, October 2012
MRSA (n = 142/271) 52.5%
MRSA vancomycin R (n = 11/142) 7.7%
Enterococcus ampicillin R (n = 64/102) 62.7%
Enterococcus vancomycin R (n = 69/102) 67.6%
E. coli cefotaxime R (n = 89/221) 40.2%
E. coli ESBL + (n = 44/221) 20.0%
Acinetobacter baumanii ceftazidimeR (n = 10/10) 100.0%
Pseudomonas aeruginosa ceftazidime R (n = 75/110) 68.2%
R, resistant; MRSA, methicillin-resistant S. aureus;
ESBL, extended-spectrum beta-lactamase.hospitals in Benin, thus constituting a representative sample
of acute care institutions in terms of region, type of wards,
hospital size, and teaching status. The total number of pa-
tients surveyed was 3130, corresponding to 65% of the full
capacity of participating centres. Occupancy rate did not
reach 100%.
Although the overall bed occupancy rate did not reach
100%, some hospitals exceeded their bed capacity oc-
casionally with more than one patient occupying the
same bed [3,5].
We observed an overall HAI prevalence of 19.1%. Surgi-
cal and medical wards showed high rates (22.3% and
24.5%, respectively) and comprised approximately half of
the total number of HAIs observed. These findings are
higher than previously reported by Bagheri Nejad et al.
and Simon et al. [5,8]. The difference might be accounted
for by different diagnostic strategies and criteria used. The
availability and use of microbiology laboratory data con-
tribute also to the increased identification of HAI. These
rates are much higher than in developed countries, where
they range from 5-10% [11,12] and well illustrate the urgentANTIBIOTICS %
Beta-lactam
86.9
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proaches to strengthen HAI prevention, surveillance, and
control in Africa.
The successful application of the HELICS project proto-
col to determine the presence of HAI patient symptoms in
a standardized manner represents a remarkable aspect of
our study. This method, often employed in Europe, was
easy to use and is probably more accurate and less variable
than previous methods, which relied heavily on interpret-
ation by the local observer and could have contributed to
higher estimates. Despite the high prevalence rate, most in-
fected patients probably go undiagnosed, mainly due to the
lack of routine surveillance and absence of facilities for
microbiological diagnosis. This reference protocol has some
limitations for use in developing countries. First, the avail-
able resources are modest and the cultural context is differ-
ent. Second, the classical community-acquired infectious
diseases, such as typhoid fever, are largely controlled in de-
veloped countries [16,17], but continue to be a common
occurrence in most African countries.
Staphylococci were the most prevalent bacteria and were
isolated from almost all types of clinical samples considered.
This result is not surprising because of its opportunistic and
ubiquitous nature [18]. S. aureus was the most common
hospital-acquired pathogen among inpatients in our study,
followed by Escherichia coli, P. aeruginosa, and enterococci.
Clostridium difficile is well established as important
bacteria in HAI in Benin. Its presence is usually associated
with a variety of clinical manifestations and also we were
limited by the availability of diagnostic tests that indicate
the presence of this microorganism.
The prevalence of antibiotic use was 64.6%, similar to
published data from Tanzania (71%) or Greece (51.4%), but
much higher than the rate reported from France (16%)
[12,19]. The most extensive use of antimicrobials in non-
infected patients was in surgical (27%) and obstetrics/gy-
naecology (18%) wards.
In our study, the treatment of 13,8% of infected patients
was a challenge by the fact that the prohibitive cost of
second-line antimicrobial drug, when available, places them
out of the reach of majority of patients.
It is imperative to preserve the effectiveness of common
antibiotics by promoting their rational use based on sound
knowledge of local resistance patterns.
Several resistant strains were identified in agreement
with previously reported findings [19,20], e.g., methicillin-
resistant S. aureus (52.5%), ceftazidime-resistant P. aer-
uginosa (68.5%), and vancomycin-resistant enterococci
(67.5%). This might be due to the fact that certain clas-
ses of antibiotics are easily accessible in Benin and fre-
quently used by patients without a medical prescription;
this represents 40% of patients on antibiotics. In our
context the self-medication was related both to other
illnesses and HAI treatment.These results are in acccordance with data reporting
the increasing antimicrobial resistance of Gram-negative
bacteria [19,21,22]. In addition, the high proportion of
multiresistant bacteria in Benin may be explained by the
practice of patient self-medication and the availability
and low price of antibiotics that can be bought without
prescription. An additional concern is the fact that some
available pharmaceuticals are of doubtful quality and fail
basic quality tests, thus raising fears that many of these
drugs may not be having the desired impact on patients.
It is therefore critical to treat HAI appropriately by start-
ing antimicrobial therapy early in the course of infection,
using the correct agent at the most appropriate dose, and
for an adequate duration. Furthermore, antibiotic steward-
ship should include patient education.
Of note, no resistance to imipenem was recorded among
pathogens identified in this nationwide survey of HAI. In
Benin, the repertoire of first-line drugs is limited to ampicil-
lin, chloramphenicol, erythromycin, gentamicin, penicillin,
tetracycline and trimethoprim-sulphathoxazole. Second-line
antibiotics include imipenen, which is currently unavailable
in Benin. Furthermore, when available, its prohibitive cost
would place it out of the reach of most patients. Thus, the
lack of use explains the absence of identified resistance to
imipenem in Benin.
Our study has limitations. First, and similar to all
point-prevalence studies, this approach tends to under-
estimate true prevalence rates and, in particular, HAI of
shorter duration. In addition, HAI that developed after
hospital discharge was not recorded. A realistic picture
of the disease pattern over time would require the con-
duct of prospective surveillance of HAIs, which is far
beyond available resources in Benin. Second, antibiotic
resistance detection was not conducted at a central la-
boratory, but the surveillance method employed did use
international standardized techniques. As multiresistant
nosocomial pathogens of high epidemiological interest
(i.e., vancomycin-resistant S. aureus) were not kept, fur-
ther diagnostic validation could not be conducted. Dif-
ferences in the sensitivity and specificity of laboratory
diagnostic techniques have been described, which might
impact on stain identification [23].
To our knowledge, this is the first study that provides
national prevalence data for HAI in Benin. Moreover, the
methodology proved feasible in the African setting and is
probably more accurate than previous methods used. In
the light of these findings, appropriate prevention mea-
sures can be proposed, such as reminders regarding hy-
giene rules and recommendations and isolation protocol,
completed by HAI surveillance. We suggest that the com-
bination of a prevalence (cheap and short, and providing a
one-day snapshot) and an incidence survey (targeted sur-
veillance of high-risk areas) provide the best picture of
HAI in settings with limited resources.
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Our results suggest that the prevalence of HAI in Benin is
at least as high as published reports from neighbouring
countries and that continued infection control efforts are
warranted. This is also the first report of national preva-
lence of HAI in Benin. We believe there is a need for a
standardized approach to HAI surveillance in Africa region.
More attention should be paid to the indiscriminate use of
antimicrobials in non-infected patients.
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